Resultados globales: 10 registros encontrados en 0.01 segundos.
Artículos, Encontrados 9 registros
Documentos de investigación, Encontrados 1 registros
Artículos Encontrados 9 registros  
1.
10 p, 2.3 MB Second-Generation Insulin Analogues - a Review of Recent Real-World Data and Forthcoming Head-to-Head Comparisons / Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Hramiak, Irene (Lawson Research Institute, London, ON, Canada) ; Universitat Autònoma de Barcelona
Insulin analogues play a key role in the effective management of type 2 diabetes. However, there are several behavioural barriers to appropriate early initiation of insulin therapy, despite compelling evidence supporting the benefits of this strategy in those patients for whom oral anti-diabetes agents provide insufficient control. [...]
2018 - 10.17925/EE.2018.14supp1.2
European Endocrinology, Vol. 14 (may 2018) , p. 2-9  
2.
14 p, 538.5 KB ViDa1: The Development and Validation of a New Questionnaire for Measuring Health-Related Quality of Life in Patients with Type 1 Diabetes / Alvarado-Martel, Dácil (Complejo Hospitalario Univesitario Insular Materno-Infantil de Gran Canaria) ; Ruiz Fernández, M. Angeles (Universidad Nacional de Educación a Distancia, Madrid) ; Cuadrado Vigaray, Maribel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Carrillo, Armando (Complejo Hospitalario Univesitario Insular Materno-Infantil de Gran Canaria) ; Boronat, Mauro (Complejo Hospitalario Univesitario Insular Materno-Infantil de Gran Canaria) ; Montesdeoca, Ana Expósito (Instituto Universitario de Investigaciones Biomédicas y Sanitarias. Universidad de Las Palmas de Gran Canaria) ; Nattero Chávez, Lía (Hospital Universitario Ramón y Cajal) ; Pozuelo Sánchez, Maite (Hospital Universitario Ramón y Cajal) ; López Quevedo, Pino (Hospital Universitario de Gran Canaria Doctor Negrín) ; Santana Suárez, Ana D. (Hospital Universitario de Gran Canaria Doctor Negrín) ; Hillman, Natalia (Hospital Universitario La Paz) ; Subias, David (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Martin Vaquero, Pilar (D-Médical Clinic, Madrid) ; Sáez de Ibarra, Lourdes (Hospital Universitario La Paz) ; Mauricio Puente, Dídac (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; de Pablos Velasco, Pedro (Instituto Universitario de Investigaciones Biomédicas y Sanitarias. Universidad de Las Palmas de Gran Canaria) ; Nóvoa, Francisco J. (Complejo Hospitalario Univesitario Insular Materno-Infantil de Gran Canaria) ; Wägner, Ana M. (Complejo Hospitalario Univesitario Insular Materno-Infantil de Gran Canaria) ; Universitat Autònoma de Barcelona
This study describes the development of a new questionnaire to measure health-related quality of life (HRQoL) in patients with type 1 diabetes (the ViDa1 questionnaire) and provides information on its psychometric properties. [...]
2017 - 10.3389/fpsyg.2017.00904
Frontiers in psychology, Vol. 8 Núm. 904 (2017) , p. 1-14  
3.
10 p, 889.7 KB Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA / Mauricio Puente, Dídac (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Meneghini,Luigi (University of Texas Southwertern Medical Center) ; Seufert, Jochen (Freiburg Universität) ; Liao, Laura (Sanofi, Bridgewater, New Jersey) ; Wang, Hongwei (Sanofi, Bridgewater, New Jersey) ; Tong, Liyue (Sanofi, Bridgewater, New Jersey) ; Cali, Anna (Sanofi, Paris) ; Stella, Peter (Sanofi, Paris) ; Carita, Paulo (Sanofi, Paris) ; Khunti, Kamlesh (University of Leicester. Diabetes Research Centre) ; Universitat Autònoma de Barcelona
Aims: To evaluate short- and long-term glycaemic control and hypoglycaemia incidence in insulin-naïve patients ≥30 years of age with type 2 diabetes (T2DM) initiating basal insulin (BI) with or without oral anti-hyperglycaemic drugs (OADs). [...]
2017 - 10.1111/dom.12927
Diabetes, Obesity and Metabolism, Núm. 19 (2017) , p. 1155-1164  
4.
9 p, 569.1 KB Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus : Are We Respecting Their Contraindications? / Ruiz Tamayo, Irene (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Franch Nadal, Josep (CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III) ; Mata Cases, Manel (Institut Català de la Salut) ; Mauricio Puente, Dídac (Hospital Universitari Germans Trias i Pujol) ; Cos, Xavier (Institut Català de la Salut) ; Rodríguez Poncelas, Antonio (Institut Català de la Salut) ; Barrot, Joan (Institut Català de la Salut) ; Coll-de-Tuero, Gabriel (Institut Català de la Salut) ; Mundet Tudurí, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina)
Aim. To assess prescribing practices of noninsulin antidiabetic drugs (NIADs) in T2DM with several major contraindications according to prescribing information or clinical guidelines: renal failure, heart failure, liver dysfunction, or history of bladder cancer. [...]
2016 - 10.1155/2016/7502489
Journal of Diabetes Research, Vol. 2016 (January 2016) , art. 7502489  
5.
10 p, 440.1 KB Direct medical costs attributable to type 2 diabetes mellitus : a population-based study in Catalonia, Spain / Mata Cases, Manel (CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM)) ; Casajuana, Marc (Universitat Autònoma de Barcelona) ; Franch Nadal, Josep (Institut Català de la Salut) ; Casellas, Aina (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Castell, Conxa (Generalitat de Catalunya. Departament de Salut) ; Vinagre Torres, Irene (Universitat de Barcelona) ; Mauricio Puente, Dídac (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bolíbar, Bonaventura (Universitat Autònoma de Barcelona)
We estimated healthcare costs associated with patients with type 2 diabetes compared with non-diabetic subjects in a population-based primary care database through a retrospective analysis of economic impact during 2011, including 126,811 patients with type 2 diabetes in Catalonia, Spain. [...]
2016 - 10.1007/s10198-015-0742-5
The European Journal of Health Economics, Vol. 17, Issue 8 (November 2016) , p. 1001-1010  
6.
9 p, 1.5 MB Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007-2013 in Catalonia: a population-based study / Mata Cases, Manel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Franch Nadal, Josep (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Real, Jordi (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Mauricio Puente, Dídac (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Objectives:To assess trends in prescribing practices of antidiabetic agents and glycaemic control in patients with type 2 diabetes mellitus (T2DM). Design: Cross-sectional analysis using yearly clinical data and antidiabetic treatments prescribed obtained from an electronic population database. [...]
2016 - 10.1136/bmjopen-2016-012463
BMJ open, Vol. 6 Núm. 10 (October 2016) , p. e012463  
7.
8 p, 898.4 KB Characteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study): a cross-sectional multicentre study in Spain / Conget, Ignacio (Hospital Clínic i Provincial de Barcelona) ; Mauricio Puente, Dídac (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ortega Basagoiti, Rafael (GlaxoSmithKline) ; Detournay, Bruno (Cemka Eval)
Several glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1Ra) have been made recently available in Spain for type 2 diabetes mellitus (DM2) treatment. There are no published data on the clinical and sociodemographic profile of patients initiating treatment with GLP-1Ra in Spain. [...]
2016 - 10.1136/bmjopen-2015-010197
BMJ open, Vol. 6 Núm. 7 (July 2016) , p. e010197
2 documentos
8.
9 p, 393.0 KB Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy / Alonso Pedrol, Núria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Traveset, Alicia (Hospital Universitari Arnau de Vilanova (Lleida, Catalunya)) ; Rubinat, Esther (Hospital Universitari Arnau de Vilanova (Lleida, Catalunya)) ; Ortega, Emilio (Fundació Clínic. Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Alcubierre, Nuria (Institut de Recerca Biomedica de Lleida) ; Sanahuja, Jordi (Hospital Universitari Arnau de Vilanova (Lleida, Catalunya)) ; Hernández, Marta (Hospital Universitari Arnau de Vilanova (Lleida, Catalunya)) ; Betriu, Àngels (Hospital Universitari Arnau de Vilanova (Lleida, Catalunya)) ; Jurjo, Carmen (Hospital Universitari Arnau de Vilanova (Lleida, Catalunya)) ; Fernández, Elvira (Hospital Universitari Arnau de Vilanova (Lleida, Catalunya)) ; Mauricio Puente, Dídac (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of mortality among subjects with type 2 diabetes (T2D), and diabetic retinopathy (DR) has been associated with an increased risk for CVD. [...]
2015 - 10.1186/s12933-015-0196-1
Cardiovascular diabetology, Vol. 14, Núm. 33 (March 2015)  
9.
7 p, 877.3 KB Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population / Aguilera, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Serra Planas, Enric (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Granada Ybern, María Luisa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pellitero Rodríguez, Silvia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Reverter, Jordi L. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Alonso Pedrol, Núria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Soldevila i Madorell, Berta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Mauricio Puente, Dídac (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Puig Domingo, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona. Departament de Medicina
Background: The glycoprotein YKL-40 is a new marker of early inflammation and endothelial dysfunction. Adiponectin is a collagen-like protein with anti-atherogenic and anti-inflammatory effects. Increased concentrations of both markers have been reported in patients with type 1 diabetes (T1D). [...]
2015 - 10.1186/s12933-015-0287-z
Cardiovascular diabetology, Vol. 14, Núm. 121 (September 2015)  

Documentos de investigación Encontrados 1 registros  
1.
171 p, 4.8 MB Tecnologies de la informació i comunicació i diabetis : estudis sobre l'accés dels pacients i la qualitat dels continguts / Giménez Pérez, Gabriel, autor ; Mauricio Puente, Dídac, supervisor acadèmic ; Webb, S. M. 1952- (Susan M.), supervisor acadèmic ; Universitat Autònoma de Barcelona. Departament de Medicina
La present tesi versa sobre dos aspectes diferents de les tecnologies de la informació i la comunicació (TIC) en relació a la diabetis. En primer lloc, hem avaluat en dos períodes de temps diferents (anys 2001 i 2013) l'accés a continguts de salut a Internet de dos grups de pacients amb diabetis tipus 1 atesos en una unitat especialitzada mitjançant un qüestionari auto-administrat. [...]
This thesis refers to two different aspects of the information and communication technologies (ICT) in the field of diabetes. Firstly we have evaluated in 2 different periods (years 2001 and 2013) the access to health contents in the Internet of two groups of patients with type 1 diabetes attended in a specialized unit, through an self-administered questionnaire. [...]

[Bellaterra] : Universitat Autònoma de Barcelona, 2016  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.